ProfileGDS4718 / 236648_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 42% 56% 45% 41% 55% 52% 41% 43% 51% 44% 46% 54% 44% 58% 47% 45% 49% 51% 37% 42% 44% 43% 50% 48% 48% 45% 45% 46% 56% 53% 55% 48% 44% 45% 43% 48% 41% 45% 61% 46% 53% 42% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2132144
GSM549102patient 115, normal, homogenized [OPG study]5.1360142
GSM549104patient 119, normal, homogenized [OPG study]5.8674256
GSM549108patient 138, normal, homogenized [OPG study]5.2850545
GSM549119patient 077, normal, homogenized [OPG study]5.0576641
GSM549133patient 032, cancer, homogenized [OPG study]5.7924355
GSM549139patient 042, cancer, homogenized [OPG study]5.5932552
GSM549099patient 107, normal, homogenized [OPG study]5.0574541
GSM549109patient 139, normal, homogenized [OPG study]5.1745543
GSM549110patient 046, normal, homogenized [OPG study]5.5664551
GSM549114patient 063, normal, homogenized [OPG study]5.1467844
GSM549122patient 082, normal, homogenized [OPG study]5.2907846
GSM549134patient 033, cancer, homogenized [OPG study]5.7445554
GSM549136patient 036, cancer, homogenized [OPG study]5.1182144
GSM549140patient 044, cancer, homogenized [OPG study]5.9540758
GSM549111patient 047, normal, homogenized [OPG study]5.3094847
GSM549113patient 057, normal, homogenized [OPG study]5.1734945
GSM549132patient 031, cancer, homogenized [OPG study]5.4559249
GSM549137patient 038, cancer, homogenized [OPG study]5.5520151
GSM549142patient 047, cancer, homogenized [OPG study]4.9795937
GSM549100patient 110, normal, homogenized [OPG study]5.1061942
GSM549107patient 135, normal, homogenized [OPG study]5.1845744
GSM549115patient 068, normal, homogenized [OPG study]5.0716343
GSM549116patient 072, normal, homogenized [OPG study]5.4759550
GSM549120patient 078, normal, homogenized [OPG study]5.4137648
GSM549131patient 030, cancer, homogenized [OPG study]5.3757348
GSM549118patient 074, normal, homogenized [OPG study]5.2174845
GSM549129patient 027, cancer, homogenized [OPG study]5.2745445
GSM549123patient 088, normal, homogenized [OPG study]5.2846846
GSM549124patient 006, cancer, homogenized [OPG study]5.9105256
GSM549126patient 015, cancer, homogenized [OPG study]5.6930253
GSM549128patient 025, cancer, homogenized [OPG study]5.8145155
GSM549103patient 117, normal, homogenized [OPG study]5.4570648
GSM549117patient 073, normal, homogenized [OPG study]5.1610844
GSM549138patient 041, cancer, homogenized [OPG study]5.2350145
GSM549141patient 045, cancer, homogenized [OPG study]5.0843543
GSM549130patient 028, cancer, homogenized [OPG study]5.3833648
GSM549101patient 111, normal, homogenized [OPG study]5.0526741
GSM549105patient 128, normal, homogenized [OPG study]5.2701245
GSM549106patient 134, normal, homogenized [OPG study]6.145361
GSM549112patient 048, normal, homogenized [OPG study]5.2670246
GSM549125patient 011, cancer, homogenized [OPG study]5.6803853
GSM549127patient 024, cancer, homogenized [OPG study]5.1103342
GSM549135patient 035, cancer, homogenized [OPG study]5.9078757